Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog

被引:25
作者
Kuhn, H
Anton, M
Gerth, C
Habenicht, A
机构
[1] Humboldt Univ, Med Sch Charite, Inst Biochem, Berlin, Germany
[2] Univ Jena, Inst Vasc Med, D-6900 Jena, Germany
关键词
eicosanoids; leukotrienes; inflammation; mutation; atherogenesis;
D O I
10.1161/01.ATV.0000074167.01184.48
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives-The mouse strain CON6, which was generated by breeding athero-resistant CAST mice into an athero-susceptible B6 background, exhibits almost complete resistance to atherosclerosis. An athero-resistance gene cluster has been localized at the central region of chromosome 6, and among the candidate genes of this locus, the 5-lipoxygenase has attracted particular attention because of its involvement in the biosynthesis of proinflammatory leukotrienes. Comparison of 5-lipoxygenase genomic sequences of B6 and CON6 mice indicated 2 conserved amino acid exchanges in the CON6 animals, but the functional impact of these mutations has not been defined. Methods and Results-We analyzed the functionality of these amino acid exchanges relative to essential catalytic properties ( specific activity, substrate affinity, and reaction specificity) and found that these mutations confer an impaired lipoxygenase and leukotriene A(4)-synthase activity when introduced into the human enzyme. In contrast, substrate affinity, enantiomer selectivity, and positional specificity remained unchanged. Conclusions-These data are consistent with the possibility that naturally occurring conservative mutations in the coding region of the murine 5-lipoxygenase gene can significantly affect enzyme activity and that this loss of function may be involved in CAST/CON6 athero-resistance.
引用
收藏
页码:1072 / 1076
页数:5
相关论文
共 22 条
[1]  
AHARONY D, 1986, J BIOL CHEM, V261, P1512
[2]   The oxidative modification hypothesis of atherogenesis: An overview [J].
Chisolm, GM ;
Steinberg, D .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1815-1826
[3]   Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice [J].
Cyrus, T ;
Witztum, JL ;
Rader, DJ ;
Tangirala, R ;
Fazio, S ;
Linton, MF ;
Funk, CD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1597-1604
[4]  
DENIS D, 1991, J BIOL CHEM, V266, P5072
[5]   Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].
Drazen, JM ;
Yandava, CN ;
Dubé, L ;
Szczerback, N ;
Hippensteel, R ;
Pillari, A ;
Israel, E ;
Schork, N ;
Silverman, ES ;
Katz, DA ;
Drajesk, J .
NATURE GENETICS, 1999, 22 (02) :168-170
[6]   Lipoxygenase genes and their targeted disruption [J].
Funk, CD ;
Chen, XS ;
Johnson, EN ;
Zhao, L .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 :303-312
[7]   Prostaglandins and leukotrienes: Advances in eicosanoid biology [J].
Funk, CD .
SCIENCE, 2001, 294 (5548) :1871-1875
[8]   12/15-lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice [J].
George, J ;
Afek, A ;
Shaish, A ;
Levkovitz, H ;
Bloom, N ;
Cyrus, T ;
Zhao, L ;
Funk, CD ;
Sigal, E ;
Harats, D .
CIRCULATION, 2001, 104 (14) :1646-1650
[9]   The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity [J].
Gillmor, SA ;
Villasenor, A ;
Fletterick, R ;
Sigal, E ;
Browner, MF .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (12) :1003-1009
[10]   Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice [J].
Harats, D ;
Shaish, A ;
George, J ;
Mulkins, M ;
Kurihara, H ;
Levkovitz, H ;
Sigal, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) :2100-2105